Hydrogel spacer injection to the meso-sigmoid to protect the sigmoid colon in cervical cancer brachytherapy: A technical report

CONCLUSIONS: The dose ratio of the sigmoid colon to HR-CTV D90 was decreased by introducing a hydrogel spacer into the meso-sigmoid. In cases where the sigmoid colon is in proximity to the cervical tumor, this novel technique can be considered to achieve better clinical outcomes.PMID:38230404 | PMC:PMC10789158 | DOI:10.5114/jcb.2023.134174

Source: Journal of Contemporary Brachytherapy - January 17, 2024 Category: Cancer & Oncology Authors: Madoka Sakuramachi Naoya Murakami Ayaka Nagao Kanako Kojima Yusaku Miyata Tairo Kashihara Tomoya Kaneda Kana Takahashi Koji Inaba Kae Okuma Yuko Nakayama Hiroyuki Okamoto Mitsuya Ishikawa Hiroshi Igaki Source Type: research